Conferences EMIT Imaging is attending in 2026–2027

LinkedIn emitimaging.com

EMIT Imaging is listed at 3 conferences on Tnuki's calendar in 2026–2027: ESGCT 2026 (on the program), AACR 2027 (exhibiting) and ELRIG Drug Discovery 2026 (exhibiting). EMIT Imaging provides molecular imaging services and radiotracer development for preclinical drug discovery and life science research. As of Oct 17, 2026.

Show
ConferenceDetailsInvolvementTnuki guide
ESGCT 33rd Annual CongressEurope’s gene & cell therapy researchersOfficial site
Hamburg, Germany ~2.5k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 poster
Attending
  • speaker
Attendee mix: Mostly academic; gene and cell therapy PIs, postdocs and clinicians, strong biotech and CDMO presence
Open the guide Search and filter attendees
AACR Annual Meeting 2027World’s largest cancer research meetingOfficial site
Orlando, FL ~23k attendees ExhibitorAs published by American Association for Cancer Research
Booth 850
Attendee mix: Mostly academic, strong biopharma presence; cancer research PIs, trainees, oncologists, translational and oncology R&D
Open the guide Search and filter attendees
ELRIG Drug Discovery 2026UK & European drug discovery scientistsOfficial site
Past London, UK ~3k attendees ExhibitorAs published by ELRIG
Booth J23
Attendee mix: Mostly industry; UK and European pharma, biotech and CRO scientists, lab heads, screening and automation groups, some academics
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows EMIT Imaging’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at EMIT Imaging

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →